GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Current Deferred Revenue

CNGGF (Cann Group) Current Deferred Revenue : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Cann Group Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cann Group's current deferred revenue for the quarter that ended in Dec. 2024 was $0.00 Mil.

Cann Group Current Deferred Revenue Historical Data

The historical data trend for Cann Group's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group Current Deferred Revenue Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cann Group Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Cann Group's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cann Group Business Description

Traded in Other Exchanges
Address
262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.

Cann Group Headlines

From GuruFocus

Half Year 2023 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Corporate Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd at Investor Update webinar Transcript

By GuruFocus Research 02-13-2024

Half Year 2021 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Full Year 2019 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024